echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > A&R: Protein mannosylation as a diagnostic and prognostic biomarker for lupus nephritis

    A&R: Protein mannosylation as a diagnostic and prognostic biomarker for lupus nephritis

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Purpose : Changes in protein glycosylation are a hallmark of immune- mediated diseases
    .


    Glycans major regulator of the inflammatory response, to distinguish between self - Important non-self molecules


    ObjectiveObjective : protein glycosylation variations are immune sign mediated diseases


    Methods : A comprehensive tissue glycomic characterization was performed in kidney specimens from patients with systemic lupus erythematosus and LN confirmed by biopsy .


    Combined with advanced tissue mass spectrometry (matrix-assisted laser desorption ionization mass spectrometry imaging), in situ characterization of sugar (using PHA leukolectin (PHA-L) Evaluation β1,6 N - acetylglucosamine β1-6- branched N - For the expression of glycans, use snowdrop agglutinin (GNA) to evaluate the expression of mannosylated N - glycans) and phenotypic analysis of in vitro sugars, and perform structural map analysis on the N- glycan library in LN tissue samples .

    MethodMethod : In from systemic lupus erythematosus and biopsy-proven LN conducted a comprehensive study to characterize tissue specimens sugar groups kidney patients


    The resultsresult : LN exhibit unique glycan characteristics: high-mannose glycans and the abundance of space is usually only found in low microbe distribution increase


    CONCLUSIONCONCLUSION : Cells mannose glycosylation LN marker, predictable CKD development, represents a potential biomarker sugar may be incorporated into LN diagnostic and prognostic algorithms


    Alves, I.


    , Santos-Pereira, B.
    , Dalebout, H.


    Alves, I.
    , Santos-Pereira, B.
    , Dalebout, H.
    , et al.
    (2021), Protein Mannosylation as a Diagnostic and Prognostic Biomarker of Lupus Nephritis: An Unusual Glycan Neoepitope in Systemic Lupus Erythematosus.
    Arthritis Rheumatol, 73: 2069-2077.
    https://doi.
    org/10.
    1002/art.
    41768 https://doi.
    org/10.
    1002/art.
    41768 Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.